Coeptis Therapeutics Hldgs I
13F holders, Q1 2026 (March 31)1holders
0new positions
0sold out
$11.22avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Coeptis Therapeutics Hldgs I in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holder was Anchor Investment Management, LLC ($79K).
- Company
- Coeptis Therapeutics Hldgs I
- CUSIP
- 19207A108
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Anchor Investment Management, LLC | 0.01% | No change | 7,000 | $79K |
"% of holder's portfolio" is COEPTIS THERAPEUTICS HLDGS I's weight in each manager's 13F, not the share of Coeptis Therapeutics Hldgs I the manager owns.